Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Castle

Showing results (331-340 of 363) with videos related to

Pageof 37
Sort By:
The International Journal of Neuropsychopharmacology|October 22, 2022
Default Mode Network Modulation by Psychedelics: A Systematic ReviewJames J Gattuso, Daniel Perkins, Simon Ruffell, et al.
JMIR Diabetes|May 9, 2023
Technology-Supported Integrated Care Innovations to Support Diabetes and Mental Health Care: Scoping ReviewMegan Racey, Carly Whitmore, Paige Alliston, et al.
CNS Drugs|November 18, 2021
Molecular Mechanisms of Psilocybin and Implications for the Treatment of DepressionSusan Ling, Felicia Ceban, Leanna M W Lui, et al.
The Australian and New Zealand Journal of Psychiatry|June 15, 2012
People living with psychotic illness in 2010: the second Australian national survey of psychosisVera A Morgan, Anna Waterreus, Assen Jablensky, et al.
Journal of Psychopharmacology (Oxford, England)|May 14, 2019
The Australian drug harms ranking studyYvonne Bonomo, Amanda Norman, Sam Biondo, et al.
Sleep|April 24, 2023
Global trends in the consumption of benzodiazepines and Z-drugs in 67 countries and regions from 2008 to 2018: a sales data analysisTian-Tian Ma, Zixuan Wang, Xiwen Qin, et al.
The Australian and New Zealand Journal of Psychiatry|December 4, 2016
Responding to challenges for people with psychotic illness: Updated evidence from the Survey of High Impact PsychosisVera A Morgan, Anna Waterreus, Vaughan Carr, et al.
BMC Psychiatry|September 9, 2016
Randomised controlled trial of a digitally assisted low intensity intervention to promote personal recovery in persisting psychosis: SMART-Therapy study protocolNeil Thomas, John Farhall, Fiona Foley, et al.
Frontiers in Psychiatry|October 24, 2022
The value of compassionate support to address smoking: A qualitative study with people who experience severe mental illnessKristen McCarter, Melissa L McKinlay, Nadine Cocks, et al.
International Clinical Psychopharmacology|November 24, 2020
Body dysmorphic disorder: a treatment synthesis and consensus on behalf of the International College of Obsessive-Compulsive Spectrum Disorders and the Obsessive Compulsive and Related Disorders Network of the European College of NeuropsychopharmacologyDavid Castle, Francesca Beilharz, Katharine A Phillips, et al.
Pageof 37

Showing results (331-340 of 363) with videos related to

Sort By:
Pageof 37
The International Journal of Neuropsychopharmacology|October 22, 2022
Default Mode Network Modulation by Psychedelics: A Systematic ReviewJames J Gattuso, Daniel Perkins, Simon Ruffell, et al.
JMIR Diabetes|May 9, 2023
Technology-Supported Integrated Care Innovations to Support Diabetes and Mental Health Care: Scoping ReviewMegan Racey, Carly Whitmore, Paige Alliston, et al.
CNS Drugs|November 18, 2021
Molecular Mechanisms of Psilocybin and Implications for the Treatment of DepressionSusan Ling, Felicia Ceban, Leanna M W Lui, et al.
The Australian and New Zealand Journal of Psychiatry|June 15, 2012
People living with psychotic illness in 2010: the second Australian national survey of psychosisVera A Morgan, Anna Waterreus, Assen Jablensky, et al.
Journal of Psychopharmacology (Oxford, England)|May 14, 2019
The Australian drug harms ranking studyYvonne Bonomo, Amanda Norman, Sam Biondo, et al.
Sleep|April 24, 2023
Global trends in the consumption of benzodiazepines and Z-drugs in 67 countries and regions from 2008 to 2018: a sales data analysisTian-Tian Ma, Zixuan Wang, Xiwen Qin, et al.
The Australian and New Zealand Journal of Psychiatry|December 4, 2016
Responding to challenges for people with psychotic illness: Updated evidence from the Survey of High Impact PsychosisVera A Morgan, Anna Waterreus, Vaughan Carr, et al.
BMC Psychiatry|September 9, 2016
Randomised controlled trial of a digitally assisted low intensity intervention to promote personal recovery in persisting psychosis: SMART-Therapy study protocolNeil Thomas, John Farhall, Fiona Foley, et al.
Frontiers in Psychiatry|October 24, 2022
The value of compassionate support to address smoking: A qualitative study with people who experience severe mental illnessKristen McCarter, Melissa L McKinlay, Nadine Cocks, et al.
International Clinical Psychopharmacology|November 24, 2020
Body dysmorphic disorder: a treatment synthesis and consensus on behalf of the International College of Obsessive-Compulsive Spectrum Disorders and the Obsessive Compulsive and Related Disorders Network of the European College of NeuropsychopharmacologyDavid Castle, Francesca Beilharz, Katharine A Phillips, et al.
Pageof 37